High- and Low-Frequency TENS with Paravertebral Ozone Therapy for Chronic Low Back Pain and Radiculopathy: A Pilot Study

Reinaldo Milla; Quintanar-Escorza  Martha Angelica; Vazquez-Raygoza Alejandra Guadalupe; Cisneros MarínMariana

doi:10.70454/IJMRE.2025.05023

Authors

Reinaldo Milla Universidada Juarez del Estado de Durango Mexico Author
Quintanar-Escorza Martha Angelica Faculty of Medicine and Nutrition, Juarez University of the State of Durango, Durango, Mexico. Author
Vazquez-Raygoza Alejandra Guadalupe Faculty of Medicine and Nutrition, Juarez University of the State of Durango, Durango, Mexico. Author
Cisneros-MarínMariana Faculty of Medicine and Nutrition, Juarez University of the State of Durango, Durango, Mexico. Author

DOI:

https://doi.org/10.70454/IJMRE.2025.05023

Keywords:

High-and low-frequency stimulation, Transcutaneous electrical nerve stimulation, Paravertebral Ozone Therapy, Chronic low back pain, Radiculopathy

Abstract

Background: Chronic low back pain (CLBP) with radiculopathy is a leading cause of disability worldwide. Conventional treatments generally have limited efficacy, high costs, and associated adverse effects.

Objective: To evaluate the efficacy and safety of high-and low-frequency TENS (HLF-TENS) with paravertebral ozone therapy (POT)in chronic low back pain (CLBP) and radiculopathy.

Methods: This non-randomized pilot study was conducted with 88 consecutive patients meeting the inclusion criteria. Participants underwent 12 sessions of combined HLF-TENS and POT, without a control group. Pain intensity, neuropathic symptoms, and disability were assessed using the Numeric Rating Scale (NRS); the modified Michigan Neuropathy Screening Instrument (MNSI), and the modified Oswestry Disability Index (ODI), respectively. Assessments were performed at baseline, midpoint, and post-treatment, with long-term follow-up (1–2 years) via telephone interviews.

Results: The study included 35 men (40%) and 53 women (60%), mean age of 51.3 years (range 20–80). Post-treatment, 80% of participants showed statistically significant improvements in pain, neuropathic symptoms, and disability. Pain NRS scores decreased from 8.58 to 1.64, neuropathic symptom scores from 7.34 to 1.14, and ODI scores from 8.05 to 2.12 (p< 0.001). At long-term follow-up (1–2 years), 80% of respondents remained asymptomatic, with no adverse effects reported.

Conclusions: The combination of HLF-TENS and POT significantly reduced pain, neuropathic symptoms, and disability in CLBP patients with radiculopathy. These findings suggest a promising, non-invasive treatment option; however, randomized controlled trials are necessary to confirm efficacy.

References

[1] GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 390(10100), 1211–1259. https://doi.org/10.1016/S0140-6736(17)32154-2

[2] Hoy, D., et al (2014). The global burden of low back pain: Estimates from the Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases, 73(6), 968–974. https://doi.org/10.1136/annrheumdis-2013-204428

[3] Nicol, V., et al (2023). Chronic Low Back Pain: A Narrative Review of Recent International Guidelines for Diagnosis and Conservative Treatment. Journal of clinical medicine, 12(4), 1685. https://doi.org/10.3390/jcm12041685

[4] Katz, J. N. (2006). Lumbar disc disorders and low-back pain: Socioeconomic factors and consequences. The Journal of Bone and Joint Surgery, 88(suppl_2), 21–24. https://doi.org/10.2106/JBJS.E.01273

[5] Geurts, J. W., et al (2018). The Impact of Chronic Discogenic Low Back Pain: Costs and Patients' Burden. Pain research & management, 2018, 4696180. https://doi.org/10.1155/2018/4696180

[6] Herman, P. M., et al (2023). Definitions of Chronic Low Back Pain from a Scoping Review, and Analyses of Narratives and Self-Reported Health of Adults with Low Back Pain. The journal of pain, 24(3), 403–412. https://doi.org/10.1016/j.jpain.2022.10.012

[7] Bogduk, N. (2009). On the definitions and physiology of back pain, referred pain, and radicular pain. Pain, 147(1–3), 17–19. https://doi.org/10.1016/j.pain.2009.08.020

[8] Numeric Rating Scale (NRS) Source: National Center for Biotechnology Information, U.S. National Library of Medicine, Medscape, National Center for Biotechnology Information, U.S. National Library of Medicine

[9] Feldman, E. L., et al (1994). Michigan Neuropathy Screening Instrument (MNSI) [Database record]. APA PsycTests. https://doi.org/10.1037/t63922-000

[10] Fairbank, J. C., et al (2000). The Oswestry Disability Index. Spine, 25(22), 2940–2952. https://doi.org/10.1097/00007632-200011150-00017

[11] Mixter, W. J., et al (1934). Rupture of the intervertebral disc with involvement of the spinal canal. New England Journal of Medicine, 211, 210–215. https://doi.org/10.1056/NEJM193408022110506

[12] Diwan, A. D., et al (2023). Intervertebral disc degeneration and how it leads to low backpain. JOR Spine, 6(1), e1231.jsp2.1231 https://doi.org/10.1002

[13] Sun, Z., et al (2020). The immune privilege of the intervertebral disc: Implications for intervertebral disc degeneration treatment. International Journal of Medical Sciences, 17(5), 685–692. https://doi.org/10.7150/ijms.42238

[14] Risbud, M. V. et al (2014). Role of cytokines in intervertebral disc degeneration: Pain and disc content. Nature Reviews Rheumatology, 10(1), 44–56. https://doi.org/10.1038/nrrheum.2013.160

[15] Stafford, M. A., et al (2007). Sciatica: A review of history, epidemiology, pathogenesis, and the role of epidural steroid injection in management. British Journal of Anaesthesia, 99(4), 461–473. https://doi.org/10.1093/bja/aem238

[16] Niu, T., et al (2018). Therapeutic effect of ozone therapy for sciatica: A systematic review and meta-analysis. Medical Science Monitor, 24, 1962–1969. https://doi.org/10.12659/MSM.906753

[17] ElAbd, R., et al (2022). Role of Electrical Stimulation in Peripheral Nerve Regeneration: A Systematic Review. Plastic and reconstructive surgery. Global open, 10(3), e4115. https://doi.org/10.1097/GOX.0000000000004115

[18] Bocci, V., et al (2015). The usefulness of ozone treatment in spinal pain. Drug design, development and therapy, 9, 2677–2685. https://doi.org/10.2147/DDDT.S74518

[19] 19 . Borrelli, E., et al (2018). The use of ozone in medicine. Annals of Medical and Health Sciences Research| Volume, 8(2):117-119

[20] Knezevic, N. N., et al (2017). Treatment of chronic low back pain - new approaches on the horizon. J Pain Res 10, 1111–1123. https://doi.org/10.2147/JPR.S132769

[21] Enke, O., et al (2018). Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis. CMAJ: Canadian Medical Association Journal = journal de l'Associationmedicale canadienne, 190(26), E786–E793. https://doi.org/10.1503/cmaj.171333

[22] Follett, K. A., et al (1993). Etiology and evaluation of the failed back surgery syndrome. Neurosurgery quarterly, 3(1), 40.

[23] Baber, Z., et al (2016). Failed back surgery syndrome: Current perspectives. Journal of Pain Research, 9, 979–987. https://doi.org/10.2147/JPR.S92776

[24] Arts, M. P., et al (2012). Clinical outcome of instrumented fusion for the treatment of failed back surgery syndrome: a case series of 100 patients. Acta neurochirurgica, 154(7), 1213–1217. https://doi.org/10.1007/s00701-012-1380-7

[25] Rodríguez-Cabrera, R., et al (2013) Incapacidad temporal para el trabajo en pacientes operados de columna. Reportepreliminar. Cir Cir;81(5):405-411.

[26] 26 . Deer, T. R., et al (2015). Perspective: Peripheral nerve stimulation and peripheral nerve field stimulation birds of a different feather. Pain Medicine, 16(3), 411–412. https://doi.org/10.1111/pme.12662

[27] 27. Yang, H., et al (2022). High-frequency electrical stimulation attenuates neuronal release of inflammatory mediators and ameliorates neuropathic pain. Bioelectronic medicine, 8(1), 16. https://doi.org/10.1186/s42234-022-00098-8

[28] 28. Eldabe, S., et al (2016). Complications of Spinal Cord Stimulation and Peripheral Nerve Stimulation Techniques: A Review of the Literature. Pain medicine (Malden, Mass.), 17(2), 325–336. https://doi.org/10.1093/pm/pnv025

[29] 29. Borrelli, E., et al (2018). The Use of Ozone in Medicine. Ann Med Health Sci Res. 8 (2), 117-119

[30] 30. Grangeat, A. M., et al (2023). The Use of Medical Ozone in Chronic Intervertebral Disc Degeneration Can Be an Etiological and Conservative Treatment. International Journal of Molecular Sciences, 24(7), 6538, https://doi.org/10.3390/ijms24076538

[31] 31. Hartvigsen, J., et al Lancet Low Back Pain Series Working Group (2018). What low back pain is and why we need to pay attention. Lancet, 391(10137), 2356–2367. https://doi.org/10.1016/S0140-6736(18)30480-X

[32] 32. Foster, N. E., et al Lancet Low Back Pain Series Working Group (2018). Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet, 391(10137), 2368–2383. https://doi.org/10.1016/S0140-6736(18)30489-6

[33] 33. Buchbinder, R., et al Lancet Low Back Pain Series Working Group (2018). Low back pain: a call for action. Lancet, 391(10137), 2384–2388. https://doi.org/10.1016/S0140-6736(18)30488-4